IRIS
BRACCI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.215
EU - Europa 10.941
AS - Asia 4.992
SA - Sud America 919
AF - Africa 104
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 31.207
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.078
GB - Regno Unito 2.765
CN - Cina 2.175
IE - Irlanda 1.494
RU - Federazione Russa 1.421
IT - Italia 1.377
SG - Singapore 1.304
SE - Svezia 952
UA - Ucraina 876
DE - Germania 807
BR - Brasile 784
FR - Francia 464
HK - Hong Kong 405
KR - Corea 341
FI - Finlandia 300
VN - Vietnam 264
ES - Italia 145
IN - India 134
CA - Canada 83
BE - Belgio 74
PL - Polonia 68
BD - Bangladesh 54
NL - Olanda 53
TR - Turchia 50
AR - Argentina 49
JP - Giappone 45
ZA - Sudafrica 33
CZ - Repubblica Ceca 31
MX - Messico 29
PK - Pakistan 29
IR - Iran 27
EC - Ecuador 25
AT - Austria 24
CI - Costa d'Avorio 24
AU - Australia 20
IQ - Iraq 19
ID - Indonesia 17
VE - Venezuela 15
IL - Israele 13
MA - Marocco 13
PH - Filippine 13
LT - Lituania 12
PE - Perù 12
RO - Romania 12
SA - Arabia Saudita 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
EU - Europa 11
CO - Colombia 10
EG - Egitto 10
AZ - Azerbaigian 9
CH - Svizzera 9
KE - Kenya 9
KZ - Kazakistan 8
DK - Danimarca 7
EE - Estonia 7
JO - Giordania 7
KG - Kirghizistan 7
PY - Paraguay 7
BY - Bielorussia 6
LB - Libano 6
RS - Serbia 6
DZ - Algeria 5
JM - Giamaica 5
NZ - Nuova Zelanda 5
PA - Panama 5
AL - Albania 4
BG - Bulgaria 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
AM - Armenia 3
BB - Barbados 3
DO - Repubblica Dominicana 3
MY - Malesia 3
OM - Oman 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
LK - Sri Lanka 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
SI - Slovenia 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
BH - Bahrain 1
CM - Camerun 1
CY - Cipro 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
Totale 31.191
Salva come PNG Salva come JPEG
Città #
Southend 2.485
Dallas 1.793
Dublin 1.478
Fairfield 1.448
Ashburn 1.003
Chandler 875
Menlo Park 839
Woodbridge 716
Jacksonville 709
Singapore 657
Santa Clara 608
Houston 570
Beijing 558
Seattle 551
Wilmington 523
Siena 499
Ann Arbor 492
Cambridge 447
Hong Kong 396
Hefei 352
Seoul 340
Moscow 327
Princeton 272
Nanjing 216
Los Angeles 189
New York 177
Munich 146
Boardman 129
Helsinki 115
Málaga 113
San Mateo 109
Shanghai 103
Milan 93
Dong Ket 91
Nanchang 89
Buffalo 88
San Diego 82
São Paulo 76
Florence 71
Rome 64
Fremont 62
Hebei 59
Shenyang 58
Council Bluffs 57
Ho Chi Minh City 57
Brussels 56
Dearborn 53
Washington 48
The Dalles 47
Tianjin 46
Bengaluru 45
London 45
Turku 43
Chicago 41
Columbus 41
Redwood City 41
Hanoi 40
Warsaw 40
Kunming 39
Toronto 38
Brooklyn 37
Jiaxing 37
Jinan 33
Redondo Beach 31
Changsha 30
Frankfurt am Main 30
Phoenix 30
Düsseldorf 29
Izmir 29
Tokyo 29
Stockholm 26
Lancaster 25
University Park 25
Abidjan 24
Johannesburg 24
Rio de Janeiro 24
Zhengzhou 24
Brno 23
Atlanta 21
Bagno a Ripoli 21
Denver 21
San Francisco 21
Chennai 20
Hangzhou 20
Amsterdam 19
Belo Horizonte 19
Dhaka 19
Guangzhou 19
Lappeenranta 19
Nuremberg 19
Brasília 18
Montreal 18
Orem 18
Venezia 17
Poplar 16
Ningbo 15
Nürnberg 15
Tappahannock 15
Gdansk 14
Norwalk 14
Totale 21.753
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 338
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment 328
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 328
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 324
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 316
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 306
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 306
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 304
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 297
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 286
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 285
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 283
11β-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts 283
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 279
A model of the rabies virus glycoprotein active site 278
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 275
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 269
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 267
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist 265
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 265
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 265
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 264
A new NT4 peptide-based drug delivery system for cancer treatment 264
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 263
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 257
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 254
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 250
Tumor imaging with tetrabranched neurotensin 249
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 248
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 247
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 245
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 241
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 239
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 239
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 237
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 230
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 229
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 228
Branched peptides as bioactive molecules for drug design 228
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 226
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 226
HIV-1 gp 120 binding to nicotinig receptors 224
Branched peptides for tumor diagnosis and therapy 223
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 223
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 222
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 221
Antibacterial peptides and analogues thereof 219
Branched Neurotensin For Tumor Targeting 219
Toxin-related antibodies with antimicrobial and antiviral activity 219
Bioactive peptides from libraries 216
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 216
An antigenic determinant common to human chorionic somatomammotropin and human growth hormone revealed by limited proteolysis of immune complexes 212
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 211
Nanoparticles exposing neurotensin tumor-specific drivers 211
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 211
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 210
HIV-1 and human myelin proteins share an antigenic determinant 208
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 206
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 206
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 203
Branched peptides as targeting agents for tumor imaging and therapy 202
Endogenous morphine modulates acute thermonociception in mice 202
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 201
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 201
Synthetic peptides in the form of dendrimers become resistant to protease activity 201
Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein 199
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 199
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 198
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 198
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 197
Branched multimeric peptides for tumor diagnosis and therapy 195
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 192
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 192
The development of antimicrobial peptides as new antibacterial drugs 191
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 191
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 189
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 188
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 188
Branched Neurotensin peptides for tumor personalized therapy 186
Synthetic peptides of rubella E1 glycoprotein for serological assays 185
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 185
Branched neurotensin for tumor targeting 185
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate 183
The antimicrobial peptide M33. An example of drug development 183
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 182
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 182
Binding of HIV-1 gp120 to the nicotinic receptor 179
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 178
Molecular basis of branched peptides resistance to enzyme proteolysis 178
Determination of antigen-specific immunoglobulin content in ascitic fluids and antisera 177
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 177
NMR studies of lysozyme surface accessibility by using different paramagnetic relaxation probes 177
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 176
Three-dimensional computation of atom depth in complex molecular structures 175
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 175
Neurotensin-derived branched peptides and uses thereof 174
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 172
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 170
Identification of a neutralizing epitope on tosv gn glycoprotein 170
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 169
Totale 22.533
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.429
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.429
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.575 0 0 0 0 138 495 279 457 331 365 236 274
2021/20222.237 155 264 150 228 131 82 109 110 97 245 203 463
2022/20233.162 185 322 408 440 340 602 61 254 240 142 124 44
2023/20242.366 79 76 235 117 101 682 817 50 9 43 17 140
2024/20254.699 96 225 524 268 569 262 169 303 366 170 530 1.217
2025/20266.231 858 1.591 1.511 1.410 861 0 0 0 0 0 0 0
Totale 31.525